Statins vs placebo or usual care: Heart failure hospitalisation (RR)
Statin therapy showed no clear difference in hospitalisation due to heart failure compared with placebo or standard of care (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Statin therapy vs placebo or standard of care Hospitalisation due to heart failure · people with chronic kidney disease not requiring dialysis Statin therapy showed no clear difference in hospitalisation due to heart failure compared with placebo or standard of care (low certainty). HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis (2023) · Cochrane Headline outcomes only | RR 0.7 [0.37, 1.32] | 1 study · 579 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis 2023 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.